1. 43/#512 Assessing robustness of an artificial intelligence derived histological biomarker across different sites of disease and in serial sections in tubo-ovarian high-grade serous carcinoma. (4th December 2022) Authors: Krishnan, Rayan; Tiu, Ekin; Krishna, Vrishab; Nimgaonkar, Vivek; Bhambhvani, Hriday; O'Donoghue, Odhran; Vrabac, Damir; Joshi, Anirudh; Liang, Brooke; Zhang, Xiaoming; Han, Lucy; Wang, Aihui; Krishna, Viswesh; Howitt, Brooke Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 44/#219 Predicting response to platinum-based chemotherapy for tubo-ovarian high-grade serous carcinoma using an artificial intelligence histopathology platform. (4th December 2022) Authors: Tiu, Ekin; Krishna, Vrishab; Nimgaonkar, Vivek; Krishnan, Rayan; Bhambhvani, Hriday; O'Donoghue, Odhran; Vrabac, Damir; Joshi, Anirudh; Liang, Brooke; Zhang, Xiaoming; Han, Lucy; Wang, Aihui; Krishna, Viswesh; Howitt, Brooke Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comprehensive integrated care for patients with sickle cell disease in a remote aboriginal tribal population in southern India. Issue 4 (18th December 2013) Authors: Nimgaonkar, Vivek; Krishnamurti, Lakshmanan; Prabhakar, Hari; Menon, Nandakumar Journal: Pediatric blood & cancer Issue: Volume 61:Issue 4(2014:Apr.) Page Start: 702 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. S3320 Increase in National Inpatient Admissions for Inflammatory Bowel Disease: 2000-2014. (October 2021) Authors: Beschloss, Alexander; Travis, Daniel; Fessehaie, Nathaniel; Tan, Erik X.; Nimgaonkar, Vivek; Bhattacharya, Abhik Journal: American journal of gastroenterology Issue: Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1 Page Start: S1368 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. S746 Infliximab Monotherapy Has Lower Rates of Treatment Discontinuation and Healthcare Utilization When Compared to Combination Therapy. (October 2021) Authors: Beschloss, Alexander; Tan, Erik X.; Nimgaonkar, Vivek; Travis, Daniel; Fessehaie, Nathaniel; Lichtenstein, Gary; Osterman, Mark; Bhattacharya, Abhik Journal: American journal of gastroenterology Issue: Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1 Page Start: S343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. S747 Increase in National Cost of Inpatient Inflammatory Bowel Disease Hospital Admissions Between 2000 and 2015. (October 2021) Authors: Beschloss, Alexander; Fessehaie, Nathaniel; Nimgaonkar, Vivek; Tan, Erik X.; Travis, Daniel; Bhattacharya, Abhik Journal: American journal of gastroenterology Issue: Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1 Page Start: S343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. S895 Long-term Outcomes of High versus Low Anti-infliximab Antibody Titers in Patients with Crohn's Disease: A Tertiary Referral Center Experience. (October 2021) Authors: Fessehaie, Nathaniel; Beschloss, Alexander; Nimgaonkar, Vivek; Tan, Erik X.; Travis, Daniel; Lichtenstein, Gary; Osterman, Mark; Bhattacharya, Abhik Journal: American journal of gastroenterology Issue: Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1 Page Start: S421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗